A SIRT2-Selective Inhibitor Promotes C-Myc Oncoprotein Degradation and Exhibits Broad Anticancer Activity

Cancer Cell - United States
doi 10.1016/j.ccell.2016.03.011
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Evaluation of Molecular Inhibitors of the C-Myc Oncoprotein

2007English

E1a Promotes C-Myc-Dependent Replicative Stress

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2013English

Over-Expression of C-Myc Oncoprotein in Oral Squamous Cell Carcinoma

ecancermedicalscience
Cancer ResearchOncology
2009English

Rogaratinib: A Potent and Selective Pan-FGFR Inhibitor With Broad Antitumor Activity in FGFR-overexpressing Preclinical Cancer Models

International Journal of Cancer
Cancer ResearchOncology
2019English

Peptide Extract From Olivancillaria Hiatula Exhibits Broad-Spectrum Antibacterial Activity

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2018English

Pre-Anchoring of Pin1 to Unphosphorylated C-Myc in a Fuzzy Complex Regulates C-Myc Activity

Structure
Structural BiologyMolecular Biology
2015English

A Novel, Dual Pan-Pim/Flt3 Inhibitor SEL24 Exhibits Broad Therapeutic Potential in Acute Myeloid Leukemia

Oncotarget
Oncology
2018English

MUC1-C Oncoprotein Promotes STAT3 Activation in an Autoinductive Regulatory Loop

Science Signaling
BiochemistryCell BiologyMolecular Biology
2011English

C-Myc Promotes Differentiation of Human Epidermal Stem Cells

Genes and Development
GeneticsDevelopmental Biology
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy